Safety and Efficacy of Belatacept Conversion Following Kidney Transplant

被引:0
|
作者
Bixby, A. [1 ]
Hampton, A. [2 ]
Ecabert, D. [1 ]
Burrelli, C. [1 ]
机构
[1] Univ Hosp Cleveland, Med Ctr, Cleveland, OH USA
[2] Ohio Northern Univ, Ada, OH USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
B212
引用
收藏
页码:S850 / S850
页数:1
相关论文
共 50 条
  • [41] Safety of Early Transition to Belatacept-Based Immunosuppression in Kidney Transplant Patients
    Schilsky, J.
    Dvorai, R. H.
    Gallay, B.
    Iskhagi, S.
    Yang, C.
    Hanlon, M.
    Saidi, R.
    Shahbazov, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S847 - S847
  • [42] BELATACEPT IN SLE KIDNEY TRANSPLANT PATIENTS
    Carrion Barbera, Irene
    Fajardo, Melissa
    Tsapepas, Demetra
    Fernandez, Hilda
    Askanase, Anca
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1694 - 1695
  • [43] Differences in high and low dose belatacept conversion effects in kidney transplant patients.
    Me Me, Hay
    Tinkham, Tyler
    Nair, Sumi
    Alasfar, Sami
    Heilman, Raymond
    Corey, Rebecca
    Budhiraja, Pooja
    TRANSPLANTATION, 2024, 108 (9S)
  • [44] Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort
    Bertrand, Dominique
    Terrec, Florian
    Etienne, Isabelle
    Chavarot, Nathalie
    Sberro, Rebecca
    Gatault, Philippe
    Garrouste, Cyril
    Bouvier, Nicolas
    Grall-Jezequel, Anne
    Jaureguy, Maite
    Caillard, Sophie
    Thervet, Eric
    Colosio, Charlotte
    Golbin, Leonard
    Rerolle, Jean-Philippe
    Thierry, Antoine
    Sayegh, Johnny
    Janbon, Benedicte
    Malvezzi, Paolo
    Jouve, Thomas
    Rostaing, Lionel
    Noble, Johan
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 13
  • [45] Overall Infectious Complications Related to Belatacept Conversion in Comparison to Tacrolimus in Kidney Transplant Recipients
    Marvin, Jennifer E.
    Azar, Marwan M.
    Belfield, Kristen D.
    Do, Vincent
    Formica, Richard
    Cohen, Elizabeth A.
    PROGRESS IN TRANSPLANTATION, 2022, 32 (04) : 351 - 356
  • [46] Conversion to Belatacept as Rescue Therapy in Kidney Transplant Recipients with Severe Graft Dysfunction.
    Oldhafer, F.
    Hiss, M.
    Schwarz, A.
    Haller, H.
    Einecke, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 744 - 744
  • [47] Conversion to Belatacept in kidney transplant recipients with chronic antibody-mediated rejection (CAMR)
    Moein, Mahmoudreza
    Gao, Shuqi X.
    Martin, Samuel J.
    Farkouh, Katie M.
    Li, Benson W.
    Ball, Angela S.
    Dvorai, Reut Hod
    Saidi, Reza F.
    TRANSPLANT IMMUNOLOGY, 2023, 76
  • [48] Belatacept Conversion in Elderly Renal Transplant Recipients
    Durst, M.
    Felix, D.
    Jorgenson, M.
    Descourouez, J.
    Astor, B. C.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 691 - 691
  • [49] Conversion to Belatacept in HIV(+) Renal Transplant Recipients
    Santeusanio, A.
    Bhansali, A.
    Shapiro, R.
    De Boccardo, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 436 - 436
  • [50] PROTEINURIA AND TYPE OF KIDNEY ALLOGRAFT INJURY IDENTIFY KIDNEY TRANSPLANT RECIPIENTS BENEFITING MOST FROM BELATACEPT CONVERSION
    Weidmann, Lukas
    Schmid, Nicolas
    Lopez, Kai Castrezana
    Mueller, Thomas
    Schachtner, Thomas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I943 - I943